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We studied the effect of iv infused TRH on the plasma levels of pancreatic islet hormones in man, under different 
Results
The arginine hydrochloride stimulated increment in glucagon (Fig. 1) , insulin and blood glucose (Fig. 2) was not influenced by TRH infusion. TSH in¬ creased in all subjects following TRH (data not shown). (Fig. 3) . TRH 110 nmol/h had no significant effect on the hypoglycaemic stimulation of PP (Fig. 4) significantly reduced compared to the control study (Fig. 4) . In all, TRH infusion was followed by increased TSH (data not shown).
Glucose clamp study. Normoglycaemia (with minor changes in blood glucose) was obtained in this study (Fig. 5) . After cessation of the infusions at 80 min a decrease in blood glucose occurred (Fig. 5) . The peripheral insulin concentration increased im¬ mediately after the insulin injection (Fig. 5) (Fig. 7) . TSH increased in all cases (data not shown).
Discussion
The results of this study do not clarify the role of TRH in the regulation of endocrine pancreas.
TRH had no effect on basal, stimulated or inhi¬ bited glucagon levels in peripheral blood. Insulin and blood glucose were unaffected by TRH, which is in agreement with earlier studies (Dolva et al. 1978 ).
In perfused rat pancreas, potentiating effect of TRH on the arginine stimulated glucagon release has been reported (Morley et al. 1979 ). In our study, where arginine was infused iv to healthy men, TRH had no effect on the glucagon release. Both experimental design and different species may explain this discrepancy.
The observed minor inhibition of glucagon re¬ lease following hypoglycaemia during TRH infu¬ sion (Fig. 3) The results from the glucose clamp study con¬ firm the observation that insulin inhibits, whereas hypoglycaemia stimulates the glucagon release (Service et al. 1978) . Stimulating effect of glucagon (Epstein et al. 1980 ) and hypoglycaemia (Wass et al. 1980) on the somatostatin release has been repor¬ ted. The effect of insulin itself (without hypogly¬ caemia) has been conflicting. cluded that TRH has no effect on the pancreatic regulation. The sensitivity to TRH in the endocrine pancreas may be different from the pituitary, and the doses of TRH which were used may be too low.
The localisation of TRH in the pancreatic islets (Martino et al. 1978) and the ability of these islets to produce and release TRH (Nielsen et al. 1982) indicate that the pancreatic TRH may be of physio¬ logical importance. It is possible that the islet TRH act on the exocrine pancreas. TRH has been shown to have a dose-dependent inhibiting effect on the pancreatic enzyme secretion in men (Gullo & Labo 1981) . This concept is supported by the recent demonstration of a 'portal venous system' in the pancreatic circulation (Fraser & Henderson 1981) . Approximately 25% of the venous blood from the endocrine islets arrives directly at the exocrine tissue (Lifson et al. 1980) . TRH from the islet may in part reach the exocrine circulation. The endo¬ crine pancreas may in part regulate exocrine pan¬ creatic function.
